3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide

DB08092ExperimentalSmall molecule

3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide is a solid. This compound belongs to the phenylmorpholines. These are aromatic compounds containing a morpholine ring and a benzene ring linked to each other through a CC or... This drug targets mitogen-activated protein kinase 14.

Formula / weight: C₁₉H₁₈FN₃O₂ · 339.3635 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL195450PubChem5326870

Structure

InChIKeyVMLSXFMXUNVCSK-UHFFFAOYSA-NSMILESFC1=CC(=CC(=C1)C(=O)NC1=CC=C2NC=CC2=C1)N1CCOCC1

Targets

Q16539MAPK14

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with 3-fluoro-N-1H-indol-5-yl-5-morpholin-4-ylbenzamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account